Health ❯ Healthcare ❯ Pharmaceuticals ❯ Clinical Trials

Drug Efficacy

Tecvayli Cuts Progression Risk 71% and Deaths 40% in Phase 3 Myeloma Trial

Regulatory discussions are planned following independent confirmation of benefit.

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity

Pirtobrutinib Extends First-Line PFS vs BR and Shows Higher Response Rates Than Ibrutinib in CLL/SLL

aTyr Pharma Lead‑Plaintiff Deadline Hits as Rival Firms Vie to Steer Securities Case

Acadia Halts Carbetocin for Prader-Willi After Phase 3 Miss